With the spread of AIDS, many HIV-1 infected women and children have been diagnosed with Kaposi's sarcoma (KS), mostly in Africa. Since the discovery of the causative agent of KS (human herpesvirus 8, HHV-8) several seroepidemiological studies have been conducted to identify groups at risk of KS. The present study was conducted in order to add some information from São Paulo, Brazil. We searched for HHV-8 antibodies in plasma samples obtained from a cohort of 108 children born to HIV-1 infected mothers, and from 15 mother-child pairs enrolled in a longitudinal study of HIV-1 vertical transmission. An in house immunofluorescence assay was used to detect anti-latent and anti-lytic HHV-8 antibodies based on the BCBL-1 cell line. No case of anti-latent antibodies and a 7.4 per cent frequency of anti-lytic antibodies were detected among children. Interestingly, the detection of HHV-8 antibodies varied according to the children's HIV-1 status; no antibodies were detected in HIV-1 non-infected children and 10.9 per cent and 8.3 per cent frequencies of antilytic antibodies in truly HIV-1 infected children and in children in whom the HIV-1 status could not be defined. Since concordant results were obtained by the analysis of plasma samples obtained from mother-child pairs and considering the children's age, the antibodies detected in the present study probably reflect maternal antibodies. Unfortunately, we were not able to determine if any case of KS occurred among mothers, but because of the risk of HHV-8 horizontal transmission, the results obtained prompt us to continue investigating groups at risk to acquire HHV-8 and to search for preventive measures to avoid virus transmission.

Download full-text PDF

Source
http://dx.doi.org/10.1093/tropej/49.4.247DOI Listing

Publication Analysis

Top Keywords

hiv-1 infected
16
hhv-8 antibodies
12
antibodies detected
12
antibodies
9
children born
8
hiv-1
8
born hiv-1
8
infected mothers
8
são paulo
8
paulo brazil
8

Similar Publications

Designing and employing enzyme inhibitors against viral enzymes is one of the innovative and efficient approaches to treating viral diseases. These inhibitors can disrupt the viral replication cycle by deactivating vital enzymes, thereby curbing the spread of viral infections by reducing their population. So far, inhibitors have been designed, validated, and introduced for these enzymes.

View Article and Find Full Text PDF
Article Synopsis
  • The study compared the costs of the current CDC 3-step HIV testing algorithm with a new single-test alternative (cobas) for efficiency in diagnosing HIV.
  • A decision-tree model estimated costs and testing needs for 1 million people, revealing significant reductions in total tests and retests required when using the alternative method.
  • Findings indicate that the new algorithm could simplify HIV testing processes, cut overall testing numbers, and keep healthcare costs stable, thereby improving patient outcomes.
View Article and Find Full Text PDF

Background: Antiretroviral treatment increases the risk of accumulation of resistance mutations that negatively impact the possibilities of future treatment. This study aimed to present the frequency of HIV-1 antiretroviral resistance mutations and the genetic diversity among children with virological failure in five pediatric care facilities in Benin.

Methods: A cross-sectional study was carried out from November 20, 2020, to November 30, 2022, in children under 15 years of age who failed ongoing antiretroviral treatment at five facilities care in Benin (VL > 3log10 on two consecutive realizations three months apart).

View Article and Find Full Text PDF

Anaemia and thrombocytopenia are blood-related irregularities linked to an increased likelihood of disease progression, leading to death in people living with human immunodeficiency virus 1 (PLHIV). Severe clinical conditions associated with human immunodeficiency 1 (HIV-1) infection may be related to blood irregularities among PLHIV. The study aimed to examine the factors correlated with blood irregularities among PLHIV receiving antiretroviral treatment in West Papua.

View Article and Find Full Text PDF
Article Synopsis
  • CAB + RPV is the first long-acting HIV treatment regimen using thigh injections, showing promising results in maintaining viral suppression.
  • The study involved 118 participants and compared pharmacokinetic changes and tolerability between thigh and gluteal injections, finding no significant differences in effectiveness.
  • Results indicated that a majority of participants preferred thigh injections, with potential plans for more flexible dosing schedules to enhance treatment convenience.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!